AMRZ vs PPG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The company exhibits a Piotroski F-Score of 4/9, indicating stable but not robust financial health, while the absence of an Altman Z-Score limits distress risk assessment. Valuation metrics suggest the stock trades at a premium to both the Graham Number ($35.19) and intrinsic value ($16.52), supported by a high P/E of 22.98 versus sector peers. Despite solid operating margins and manageable leverage, earnings growth is negative year-over-year and quarterly earnings surprises have been inconsistent. Analysts recommend a 'buy' with a target price of $60.08, implying upside, but weak recent price performance and lack of dividend or insider activity temper near-term conviction.
PPG exhibits a stable but mediocre financial health profile with a Piotroski F-Score of 4/9 and no Altman Z-Score provided. The stock is trading at a significant premium to both its Graham Number ($74.39) and its growth-based Intrinsic Value ($48.44), suggesting a stretched valuation. While the company maintains a strong ROE of 21.08% and a sustainable dividend payout, these are offset by negative YoY EPS growth (-6.2%) and a bearish technical trend. The disconnect between the analyst 'Buy' consensus and the deterministic value scores indicates a potential value trap or a market expectation of recovery not yet reflected in the fundamentals.
Compare Another Pair
Related Comparisons
AMRZ vs PPG: Head-to-Head Comparison
This page compares Amrize Ltd (AMRZ) and PPG Industries, Inc. (PPG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.